About the Cervical Cancer Screening Session
Cervical cancer screening has revolutionized cancer research by enabling early detection and prevention. Techniques like the Pap smear and HPV testing have significantly reduced cervical cancer mortality rates by detecting precancerous lesions before they progress. Additionally, advancements in molecular biology have led to the development of more accurate and efficient screening methods, such as liquid-based cytology and HPV DNA testing. These innovations allow for earlier intervention, leading to improved patient outcomes and reduced healthcare costs. Moreover, ongoing research focuses on enhancing screening protocols, including the exploration of novel biomarkers and the integration of artificial intelligence for more precise diagnosis. Ultimately, cervical cancer screening continues to evolve, promising further strides in early detection and prevention strategies.
Topics Covered in Cervical Cancer Screening
HPV Primary Testing
Liquid-Based Cytology
Self-Sampling
Colposcopy Triage
Screening Intervals
Vaccinated Populations
Related Scientific Sessions at CIOC 2027
Why Attend the Cervical Cancer Screening Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cervical Cancer Screening work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cervical Cancer Screening research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cervical Cancer Screening track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cervical Cancer Screening Conference 2027 — FAQs
What is the Cervical Cancer Screening track at CIOC 2027?
The Cervical Cancer Screening track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cervical Cancer Screening. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cervical Cancer Screening sessions?
Cancer researchers and clinicians, educators and students with an interest in Cervical Cancer Screening are all welcome — whether presenting or attending.
Can I present my research in the Cervical Cancer Screening track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cervical Cancer Screening sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cervical Cancer Screening track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.